Not provided
Not provided
Not provided
Not provided
Not provided
Problems of the MST device
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial attempts to evaluate the treatment efficacy of magnetic seizure therapy (MST) and its safety among schizophrenia patients. Half of the participants will be randomized to MST group, while the other half will be randomized to receive electroconvulsive therapy (ECT).
Magnetic seizure therapy (MST) is likely to be an alternative options to electroconvulsive therapy (ECT).
Widespread stimulation of cortical and subcortical regions is inevitable for ECT since the substantial impedance of the scalp and skull shuts most of the electrical stimulus away from the brain. Nevertheless, magnetic pulses are capable to focus the stimulus to a specific area of the brain because they can pass the scalp and skull without resistance. In Addition, electric current will penetrate into deeper structures, while magnetic stimulus are only capable to reach a depth of a few centimeters. As a consequence, MST are able to generate focus stimuli on superficial regions of the cortex while ECT can't, which may give MST the capability to produce comparable therapeutic benefits with the absence of apparent cognitive side effects.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| magnetic seizure therapy | Experimental | 10 treatment sessions of MST, three times per week in the first two weeks, two times per in the following two weeks. |
|
| electroconvulsive therapy | Active Comparator | 10 treatment sessions of modified-ECT, three times per week in the first two weeks, two times per in the following two weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Magpro X100 + Option | Device | In addition to treatment as usual (TAU), participants were supposed to receive ten sessions of MST in four weeks, with three sessions per week in the first two weeks and two sessions per week in the following two weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| changes of The Positive and Negative Syndrome Scale (PANSS) | At baseline, 4-week, 8-week |
| Measure | Description | Time Frame |
|---|---|---|
| changes in motor threshold (MT) | using single-pulse Transcranial Magnetic Stimulation (sTMS) | At baseline and the day after the first treatment |
| changes in brain gamma-aminobutyric acid (GABA)levels |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Chunbo Li, PHD | Shanghai Mental Health Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Shanghai Mental Health Center | Shanghai | Shanghai Municipality | 200030 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40032619 | Derived | Li J, Wang J, Yang Y, Gao J, Zhang X. The Effect of Electroconvulsive and Magnetic Seizure Therapy (MST) on Cortical Thickness in Schizophrenia. CNS Neurosci Ther. 2025 Mar;31(3):e70309. doi: 10.1111/cns.70309. | |
| 39178051 | Derived | Jiang J, Li J, Xu Y, Zhang B, Sheng J, Liu D, Wang W, Yang F, Guo X, Li Q, Zhang T, Tang Y, Jia Y, Wang J, Li C. Does Electroencephalography Seizure Duration Account for an Adequate Treatment of Magnetic Seizure Therapy for Schizophrenia? J ECT. 2025 Mar 1;41(1):55-61. doi: 10.1097/YCT.0000000000001047. Epub 2024 Aug 21. |
Not provided
Not provided
No plan to share IPD data
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| ThymatronSystem Ⅳ Electroconvulsive System | Device | In addition to treatment as usual (TAU), participants were supposed to receive ten sessions of modified ECT in four weeks, with three sessions per week in the first two weeks and two sessions per week in the following two weeks. |
|
|
| treatment as usual (TAU) | Other | Participants will engage in their inpatient treatment program as-usual. |
|
| At baseline, the day after the first treatment, and at 4-week follow-up |
| changes in resting state network | measured by Magnetic Resonance Imaging (MRI) | At baseline, the day after the first treatment, and at 4-week follow-up |
| changes in auditory evoked potential (AEP) | measured by electroencephalogram (EEG) | At baseline and the day after the first treatment |
| changes in Novel P300 | measured by electroencephalogram (EEG) | At baseline and the day after the first treatment |
| changes in blood brain-derived neurotrophic factor (BDNF) | At baseline and at 4-week follow-up |
| changes in Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) | At baseline, 4-week, 8-week |
| 34899429 | Derived | Jiang J, Li J, Xu Y, Zhang B, Sheng J, Liu D, Wang W, Yang F, Guo X, Li Q, Zhang T, Tang Y, Jia Y, Daskalakis ZJ, Wang J, Li C. Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial. Front Psychiatry. 2021 Nov 25;12:770647. doi: 10.3389/fpsyt.2021.770647. eCollection 2021. |